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Objective: To determine the incidence of first seizures, epilepsy and seizure 
mimics in a geographically defined area using the updated 2014 International 
League Against Epilepsy (ILAE) definition which allows an epilepsy diagnosis 
following a single seizure where risk of further seizures over the next 10 years 
is approximately 60% or more. This replaced the 1993 definition where 
epilepsy was diagnosed when a person had two or more seizures separated 
by 24 hours.    
Methods: Using multiple overlapping methods of case ascertainment followed 
by individual case classification by an epileptologist we identified all first 
seizures, new diagnosis of epilepsy, and seizure mimics occurring in a 
defined geographical area (population 542,868) 01/01/2017-12/31/2017. 
Incidence was age-standardised to the Standard European Population. We 
compared incidence rates when using the 2014 and 1993 ILAE definitions. 
Results: When applying the 2014 ILAE definition of epilepsy the incidence of 
new diagnosis of epilepsy was 62 per 100,000 (age-standardised 74), 
compared to 41 per 100,000 (age-standardised 48) when applying the 1993 
definition, and the difference was more pronounced at older ages. The 
incidence of all first seizures and of seizure mimics was 102 per 100,000 
(age-standardised 123) and 94 per 100,000 (age-standardised 111), 
respectively. The most frequently encountered seizure mimic was syncope. 
Conclusion. Application of the 2014 ILAE definition of epilepsy resulted in 
higher incidence of new diagnosis of epilepsy compared to the 1993 definition. 
The incidence of seizure mimics almost equals that of all first seizures. 















Epilepsy is a notable cause of disability and mortality1 and poses a substantial 
economic burden for health care systems, individuals and their families.2 
Detailed reporting of incidence studies of epilepsy has been called for to 
address gaps in knowledge of incidence of seizures and epilepsy by age, 
seizure type and aetiology.1, 3 Expert assessment of patients presenting with 
first seizures is critical to differentiating epileptic seizures from other 
conditions that resemble epileptic seizures (‘seizure mimics’). Although first 
seizures and epilepsy are susceptible to misdiagnosis, to our knowledge there 
are no published incidence studies on seizure mimics.  
 
A recent meta-analysis of 13 studies estimated that the incidence of epilepsy 
was 61.44 per 100,000 persons-years (95%CI 50.75-74.38).3 However, there 
was significant heterogeneity of the estimate between studies, with reported 
incidence rates ranging from 33.9 to 215 per 100,000 person-years.  Possible 
explanations for such differences may be country-level income, case 
ascertainment methods or differing definitions of epilepsy. In an effort to 
promote consistency in methods used in epidemiologic studies and to 
facilitate comparisons between populations, the International League Against 
Epilepsy (ILAE) has proposed standards for epidemiologic studies and 
surveillance of epilepsy.4 
 
Previously, in both epidemiologic studies and clinical practice, the diagnosis of 
epilepsy required two or more unprovoked seizures occurring at least 24 
hours apart.5 In 2014, the ILAE updated its operational definition of epilepsy,6 
such that a person can now be diagnosed with epilepsy following a single 
unprovoked seizure if it is estimated that he or she has an approximate 60% 
or greater risk of recurrent seizures over the next ten years. In 2017, Aaberg 
et al.7 reported a 3% higher incidence of epilepsy when the 2014 definition6 
was applied to a cohort of children aged up to ten years compared to the 1993 
definition.5 To our knowledge, this updated operational definition has not yet 




2.1 Base population  
 
This study was carried out in the geographically defined area of Cork city and 
county, Ireland, with an estimated population of 542,868, predominantly 
Caucasian (93%), adults and children based on national census data from 
2016.8 The area contains one large urban development which encompasses 
approximately one quarter of the total population (125,657 adults and 
children). The remaining population lives in smaller towns, villages or rural 
dwellings. The geographic area spans approximately 7,500 km2. We report 











2.2 Case ascertainment and classification  
 
A detailed description of the epidemiologic protocol applied to this population 
has been previously published.10 In brief, multiple over-lapping sources of 
case ascertainment were applied to the geographically defined area from 1st 
January 2017 to 31st March 2018 in order to capture all cases of possible first 
seizure, new diagnosis of epilepsy and seizure mimics whose first interaction 
with medical services for the event occurred during the calendar year 2017. 
Case ascertainment relied on a combination of prospective and retrospective 
methods in both community and hospital settings, see Figure 1. All patients 
who presented to medical services during the calendar year 2017 with a 
possible first seizure or new diagnosis of epilepsy whose address, as per the 
hospital based administrative system, was within the geographically defined 
area were included. In accordance with the ILAE epidemiologic guidelines,4 
neonatal seizures and febrile seizures were excluded. Cases with inadequate 
or unclear documentation were classified as indeterminate. Epileptic seizures 
and epilepsy were defined according to the ILAE operational definitions.6, 11 
Epilepsy type was classified as focal, generalised or unknown according to 
the 2017 ILAE Commission report.12 Provoked seizures13 were identified as a 
specific sub-cohort, and were separated from first unprovoked seizures and 
epilepsy.   
 
Following the identification of a potential case, the medical-chart and 
investigations of the patient were reviewed first-hand.  In accordance with the 
ILAE epidemiologic study guidelines,4 the probability that an event was a 
seizure was defined as either a definite, probable or possible based on the 
evidence available, as follows:  
i) Definite: with primary documentation of (a) epileptic seizures, with evidence 
that these were unprovoked by any acute medical condition or transient brain 
disorder or (b) documentation of diagnosis by someone with appropriate 
specialised training in the recognition of seizures/epilepsy. Clear evidence of 
epileptic seizures was most often based on documented collateral history or 
documented history by medical staff in the case on inpatient events.  
ii) Probable: with other sources of information indicating the likelihood that 
criterion (a) or (b) above is met. Cases were defined as probable where the 
clinical history was strongly suggestive of an epileptic seizure, but a witness 
history was not recorded, for example a patient found alone in collapsed 
unresponsive state with seizure markers such as tongue biting. 
iii) Possible: where primary or other sources of information suggest a 
possibility of epilepsy but neither (a) or (b) above is met. Possible epileptic 
seizures were defined as an event of which an epileptic seizure was one of a 
number of plausible differential diagnoses, but of which it was not possible to 
determine which was the most likely.  
 
Patients who initially had a working diagnosis of epileptic seizure as judged by 
a first-line decision-maker (for example, an emergency department physician, 
general practitioner (GP)), but who were ultimately determined not to have 
had a seizure (by an epileptologist, senior neurologist or senior physician), 
were classified as ‘seizure mimics’. Based on the evidence available from 










specific alternate diagnosis to a seizure was specified where possible. 
Patients who were determined not to have had a seizure, but in whom it was 
not possible to assign a specific diagnosis, were labelled as unclassified 
seizure mimics.  
 
The 2014 ILAE operational definition of epilepsy6 outlines that following a 
single unprovoked seizure a person with an estimated approximate 60% or 
greater risk of further seizures occurring over the next 10 years can be 
diagnosed with epilepsy. Definite, probable and possible single unprovoked 
seizures were classified as definite, probable or possible epilepsy, 
respectively, if one or more of the following risk factors were identified: 
persons with a structural or remote symptomatic aetiology and/or epileptiform 
abnormality on electroencephalogram (EEG)14-16 adults with a significant 
structural brain imaging abnormality,15, 17, 18 neurodegenerative dementia,19 or 
extensive small vessel disease with juxtacortical lesions.20 Central to the 
quantification of risk was a clinical judgement by an experienced epileptologist 
(DC and EC) on how likely was a patient to have further seizure(s) over the 
next 10 years if not started on an anti-epileptic drug (AED). Patients with two 
or more seizures were also classified as having epilepsy. This classification 
was independent of whether the treating physician had commenced the 
patient on an AED. Patients with mild-to-moderate small vessel disease 
without juxtacortical involvement, other non-specific findings or normal 
investigations were classified as a single unprovoked seizures.  
 
As outlined previously,10 we applied a novel method of assessment of case 
under-ascertainment to the defined area by prospectively following a cohort of 
patients determined to be at high risk of seizures.21, 22 A neuro-oncology 
multidisciplinary meeting occurred twice a month in the tertiary level hospital 
to discuss cases from the hospital catchment area with a primary or 
secondary brain tumour. Patients identified at the multidisciplinary meeting 
from January 2017 to June 2017 were prospectively followed until 2018. Case 
notes were reviewed in March 2018 to determine if a patient had been 
diagnosed with a seizure or epilepsy during the calendar year 2017. If a new 
diagnosis of seizure or epilepsy had occurred, the patient was cross-
referenced to our study database to determine if they had been ascertained 
through one of the overlapping methods of case ascertainment.  
 
2.3 Statistical analysis 
 
Demographic data are presented as median and interquartile range. Only 
definite and probable cases of seizures and epilepsy were included in the 
calculation of incidence and analysis of aetiology. Demographic data from All 
Ireland Census 20168 was used to calculate annual age-group and sex-
specific incidence per 100,000 population. Ninety-five percent confidence 
intervals were calculated for annual incidence. Age-standardisation was 
performed by comparison to the 2013 European Standard Population.23 
Eurostat does not provide information on certain age groups, for example, 
those aged less than one. Therefore, for age standardisation 5-year age 
groups were used. Statistical analyses were performed using SPSS version 











2.4 Standard Protocol Approvals, Registrations, and Patient Consents 
 
The study protocol was approved by the University College Cork Clinical 
Ethics Research Committee. Following ascertainment, the data were 
anonymised prior to analysis and storage.  
 
2.5 Data Availability 
 




3.1 Case capture and inclusion  
 
Figure 1 illustrates the study overview and the number of cases ascertained 
and classified in each of the four diagnostic categories of first provoked 
seizure, first unprovoked seizure, new diagnosis of epilepsy and seizure 
mimic. The most common reason for exclusion was an absence of a plausible  
clinical query of an epileptic seizure on chart review (n=194, 32% of excluded 
cases). For example, cases for whom an EEG was ordered for a clinical query 
of rapidly progressive dementia. Eight patients had both a first provoked and a 
first unprovoked seizure during the study period. One patient presented with a 
first provoked seizure secondary to a haemorrhage from a cavernoma and 
was classified as epilepsy because brain imaging showed multiple other 
cerebral cavernomas thus the patient was judged to be at approximately 60% 
or greater risk of recurrent seizures. 
 
Of the 1330 cases included, 54% (n=722) were identified by a single source 
and 46% (n=608) were identified by multiple sources. Out of up to 8 sources 
of case ascertainment, the maximum number of methods that any individual 
case was captured by was 6 (n=3). Review of EEG databases provided the 
largest number of included cases (n=748, 56%) and the largest number of 
unique-to-source cases (n=302, 23%). 
 
3.2 Incidence and classification 
 
The sex- and age-group specific and total unadjusted and age- standardised 
incidence of all definite and probable first seizures, new diagnosis of epilepsy, 
and seizure mimics are presented in Table 1.  The incidence was higher in 
males than females in all diagnostic groups with the exception of seizure 
mimics. The incidence of each diagnostic group was bimodal with highest 
incidences in those under one and over 65 years of age, see Figure 2.  
 
Seventy-one percent (n=240) of definite and probable new diagnosis of 
epilepsy were classified as focal, 11% (n=37) were classified as generalised 
and 18% (n=59) had an unknown epilepsy type. Structural aetiology 
represented the most common aetiology of epilepsy (54%, n=182). Thirty 
percent (n=102) of definite and probable cases of epilepsy had an unknown 










of epilepsy, either genetic generalised epilepsy (9·5%, n=32) or gene specific 
disorders (2%, n=7).  
 
In order to compare incidence with previous studies, we calculated the 
incidence of epilepsy in our population using the 1993 ILAE definition5 (i.e. a 
history of two or more unprovoked seizures), see Table 2.  Similar to the 2014 
ILAE definition,6 incidence displayed a bimodal age distribution, see Figure 3. 
The annual incidence increased when the 2014 definition6 was applied as 
compared to the 1993 definition5 in all age groups and this increase was 
greatest in older age groups. Ninety-one percent (n=307) of patients with a 
definite or probable diagnosis of epilepsy according to the 2014 definition6 
were prescribed an AED. Ninety-three percent (n=206) of those with a definite 
or probable diagnosis of epilepsy according to the 1993 definition5 were 
prescribed an AED. 
 
The incidence of seizure mimics was almost equal to the incidence of first 
seizures, see Figure 4 and Table 1. In older age groups, a diagnosis of first 
seizure became more likely than a diagnosis of seizure mimic. Vasovagal 
syncope and convulsive syncope constituted almost half of the seizure mimics 
(47%, n=238). Of patients who were admitted to the hospital for more than 24 
hours, the median length of stay was 5 days (interquartile range 9) for all first 
seizures (n=722) and 4 days (interquartile range 7) for all seizure mimics 
(n=510). 
 
3.3. Assessment of under ascertainment 
 
In March 2018, we reviewed the medical notes of 155 patients discussed at 
the neuro-oncology meeting from January to June 2017. Of these, 54% 
(n=83) were excluded as they resided outside of the study catchment area, 
15% (n=23) had a history of seizures prior to 2017, and <1% (n=6) were 
discussed due to spinal cord lesions and were therefore not relevant to the 
study. Of the remaining 43 who were eligible for inclusion, 8 had their first 
seizure during 2017 (19%). Seven of these patients were captured through 
our previously described methods of ascertainment. One remaining patient 
diagnosed with epilepsy during the study period was not captured by our 
methods. This patient was admitted directly under the medical oncology team 
and the initial clinical query was not of seizure. However, the attending neuro-
oncologist felt the recurrent stereotyped events for which the patient was 
admitted were focal seizures and commenced an AED. The patient did not 




We sought to estimate incidence of first seizures, new diagnosis of epilepsy, 
and seizure mimics in a defined geographical area adhering to ILAE 
guidelines. The ILAE made a significant change in 20146 by introducing the 
operational definition of epilepsy, allowing a person to be diagnosed with 
epilepsy following a first unprovoked seizure if there is an estimated 60% or 
greater risk of recurrent seizures over the next 10 years. The motivation for 










unnecessary risk of physical injuries or social consequences of recurrent 
seizures in patients judged to be susceptible to a high risk of recurrence. In 
our whole population study, we found that application of the 2014 definition6 
resulted in a 54% higher age-standardised incidence of new diagnosis of 
epilepsy compared to the 1993 definition.5 The higher incidence epilepsy was 
more pronounced at older ages. There are a number of possible explanations 
for the observed difference in incidence.  First, the 2014 definiton6 may ‘shift’ 
the diagnosis to an earlier time-point, creating an early peak in a population 
whose incidence, if followed for a longer period, would ultimately be the same 
if the 1993 definition5 were applied.   According to the 2014 definition,6 a 
follow up period of 10 years is needed to verify if such a shift has occurred. 
Alternatively, or concurrently, the 2014 definition6 may be less specific than 
the 1993 definition,5 allowing diagnosis of epilepsy in persons who will never 
go on to have a second seizure. This issue is complicated by commencement 
of an AED that, at least in the short-term, reduces the risk of a second seizure.  
 
The annual incidences we report when using the 1993 definition5 and the 
2014 definition6 appear to diverge as age increases. In those up to 10 years 
of age, the incidence was 28% higher whereas in those over 45 years of age 
the incidence was 78% higher using the 2014 definition.6 Structural 
aetiologies such as brain tumours and cerebrovascular disease are more 
prevalent in older populations, and may therefore lead to a higher incidence 
when the 2014 definiton6 is applied.  
 
Aaberg et al.,7 reported a 3% higher annual incidence of epilepsy in a cohort 
of Norwegian children aged 0 to 10 years when the 2014 definition6 was 
applied compared to the 1993 definition.5 The annual incidence of epilepsy in 
children aged 0 to 10 years according to the 20146 definition was similar in 
our population compared to the Norwegian cohort, specifically 68 versus 72 
per 100,000. However, the annual incidence according to the 19935 definition 
was lower in our population, 53 compared to 70 per 100,000 in the Norwegian 
cohort, resulting in a greater proportionate change. One possible explanation 
could be that a smaller proportion of children in our population had two 
seizures during the study period. We undertook our study in 2017 when the 
2014 operational definiton6 was in place whereas the ILAE definition changed 
during the Norwegian study period. It is possible that children were 
commenced on an AED at an earlier stage in our population resulting in lower 
second seizure rates, though further investigation of this point is necessary to 
clarify this. Aaberg et al.,7 suggested that application of the new definition may 
be most relevant in adult populations, as has been shown by our data.  
 
In practical terms, the diagnosis of epilepsy often translates to a patient being 
commenced on an AED. Our data demonstrated that over 90% of patients 
were prescribed an AED in both the 19935 and 20146 definition groups. From 
a healthcare management and planning point view, these patients require 
longitudinal care.  
 
In daily clinical practice, determining if a patient has an approximate 60% or 
greater risk of recurrent seizures can be difficult, particularly if seizures occur 










for example if a patient has a remote history of a cortical infarct.18 The 
Multicentre Trial for Early Epilepsy and Single Seizures (MESS)24 attempted 
to clarify risk for patients who had a single unprovoked seizure and in whom 
neither the doctor or patient had a strong view as to whether to start an AED. 
However, that study did not include neuroimaging as part of risk assessment. 
There remains a lack of up-to-date, prospective studies to aid clinicians in 
accurately assessing risk for an individual patient, especially if a person has 
more than one risk factor for development of epilepsy. Neurologists and 
physicians may act on experience and gestalt rather than evidence when 
prescribing an AED when a patient presents after a first seizure. Importantly, 
the 2014 definition6 does not require the clinician to estimate the risk exactly. 
While this is important clinically, given the absence of specific data in many 
cohorts, this issue may make future comparisons between epidemiologic 
studies difficult as an operational definition which allows clinician’s experience 
to inform risk may not be standardised across countries or even regions.   To 
our knowledge, this study is the first to report whole population incidence data 
since the 2014 definition6 update and therefore provides useful and current 
information to practicing physicians, neurologists, epileptologists and 
epidemiologists.  
 
The diagnostic issue of seizure-mimics is one that is frequently encountered 
by clinicians. Though it is known that epilepsy and seizures are subject to 
misdiagnosis,25 to our knowledge, no incidence data of seizure mimics within 
a defined population have been reported. Our study is unique in that seizure 
mimics were captured simultaneously with first seizures and epilepsy cases, 
and therefore provides an opportunity to compare the occurrence of these 
disorders within a population over a given period of time using the same 
methodology. We were careful to include only patients where the working 
diagnosis was explicitly stated as a ‘seizure’ by frontline medical personnel.  
By combining the standardised incidence of first seizures and seizure mimics 
demonstrated by our study, healthcare systems can expect 234 presentations 
per 100,000 per year. However, the burden of seizure mimics may vary 
significantly between different populations depending on experience of clinical 
personnel and access to health resources and specialist assessments such 
as syncope clinics and clinical care pathways. Therefore caution is needed 
applying this figure to other populations and healthcare systems. Nonetheless 
in most countries patient presenting with seizure mimics are likely to first 
present to emergency department staff, general physicians or general 
neurologists. Only 13% (n=68) of the seizure mimics captured in our 
population were seen in the rapid access seizure clinic (RASC) of whom 13% 
(n=9) had been commenced on an AED prior to referral, the majority for 
convulsive presentations. Similar to first seizures, these cases require 
significant resources in terms of early investigations. Correct diagnosis of 
seizure mimics early in the clinical course prevents inappropriate AED 
medication and, in some cases, may detect potentially dangerous conditions 
such as cardiogenic syncope.  
 
The ILAE has called for further incidence studies with an emphasis on valid, 
reproducible methodology and detailed reporting of results.4 A major strength 










individual case analysis in a previously unstudied geographic area and 
reporting of results in accordance with updated ILAE definitions6 and 
classification systems.12 In terms of epidemiologic data, our methodology 
highlights some important issues. First, based on our results, studies which 
rely heavily on human participants to alert investigators of potential cases may 
significantly under-ascertain cases, as evidenced by the fact that the majority 
of our cases came from hospital-based databases. Furthermore, with regard 
to our assessment of under ascertainment, the single case which was not 
identified relied solely on reporting by healthcare personnel for inclusion as 
the person did not have specific radiology or neurophysiology tests for a 
potential seizure. This highlights the understandable difficulty in recall for busy 
clinicians and nurse specialists, and the importance of health record data to 
aid epidemiologic studies. Second, while EEG databases provided the largest 
number of cases, only 56% of cases were identified by this method, 
underlining the need for multiple methods of case ascertainment. In our study, 
all but three cases were identified by five or fewer methods of ascertainment, 
despite up to 8 being possible. Within the practical confines of our healthcare 
setting, this demonstrates maximal use of the available case ascertainment 
methods.  
 
Over the last four decades, ascertainment methods for epidemiologic studies 
have progressed and guidelines for accurate methodologies and reporting of 
epidemiologic studies4, 9 allow easier comparison between studies. Table 3 
compares the current study to previously published whole population data in 
terms of case ascertainment methodology and incidence results. When using 
the 1993 ILAE definition5 of epilepsy, our results are within the range of other 
studies in industrialised countries. Furthermore, the bimodal age-specific 
incidence shown in our study has been previously documented in other 
populations,26, 27, 29-31, 35, 37, 39, 43 reinforcing the validity of our results. As 
previously noted, incidence of epilepsy appears to be highest in developing 
countries,28, 32, 38, 39 possibly due to the presence of central nervous system 
infections, consanguinity and perinatal risk factors.3 Application of the 2014 
definition6 to these populations could result in even higher incidence of 
epilepsy.  
 
The vast majority of cases of first seizures are referred to secondary or 
tertiary level care in the geographic area studied. The RASC operates a 3-4 
week waiting list for new referrals and is readily accessible to GPs. The 
majority of GPs would not commence or titrate AEDs in the community 
without specialist input. An exception may be a patient with advanced 
dementia or physical disability who may be treated locally by the GP, thus 
prompting community survey as part of our case ascertainment. Four percent 
(n=51) of cases were ascertained by either GP or nursing home survey, of 
which 10% (n=5, <1% of total) were unique to community based 
ascertainment methods (data not shown). The low level of ascertainment is 
likely explained by the our sampling frequency; we wrote to GPs on a three 
monthly basis and nursing homes on a six monthly basis10 and therefore 
recall of new cases can be understandably low. MacDonald et al.,33 were 
unique in their intense liaison with a cohort of 13 practises in whom all GPs 










diagnosis. It would not have been practical within the geographical area 
included in our study, which included over 350 GPs and 120 nursing home 
and residential care facilities, to liaise on a more regular basis. For the 
reasons outlined above, we do not expect that the low level of ascertainment 
from community sources will have resulted in significant under-ascertainment 
of unique cases.  
 
Unlike many previous studies, we did not use hospital medical record coding 
data. Hospital Inpatient Enquiry (HIPE) data in Ireland is not designed for 
research and the validity of HIPE data with regard to epilepsy is unknown. 
Furthermore, seizures occurring in medically unwell patients admitted for 
other reasons may not be coded. HIPE data does not differentiate between 
new onset seizures and admission for established epilepsy. Finally, HIPE data 
is not available for private hospitals. Hernandez-Ronquillo et al.,26 and 
Giussani et al.,27 using solely medical record coding data, report higher crude 
annual incidence than in our population. However, individual case validation 
was not performed in either study and therefore accuracy of diagnosis and 
coding is unknown. In contrast, Annegers et al.,34 used coded data to identify 
cases followed by individual case validation and report annual incidence lower 
than our population, which may be explained by the small numbers of persons 
over 65 years in that study. In populations with a very well developed and 
detailed medical record linkage database, such as Rochester Minnesota,37, 43 
information on seizure and epilepsy type can be obtained. However, HIPE 
data in Ireland does not provide this level of detail. Therefore, we did not 
anticipate that hospital medical record data would significantly improve either 
the sensitivity of case ascertainment or the detail of case classification in our 
population.10 Ultimately, the case ascertainment methods used in a particular 
population must be individually designed for maximal case ascertainment 
within the confines of the healthcare system of that population.4 
 
We acknowledge that some patients may have a first seizure in 2017 and not 
seek medical attention. For some of these patients a diagnosis of epilepsy will 
be made in the future if they present with further seizures. On the other hand, 
there is no reason to expect that the number of these potentially missed cases 
would differ from the numbers of patients included who had seizures prior to 
2017 but first sought medical attention in 2017, yielding no net loss in 
incidence.  
 
In summary, using multiple methods of case ascertainment we estimated the 
incidence of first seizures (provoked and unprovoked), new diagnosis of 
epilepsy and seizure mimics.  Application of the 2014 ILAE definition of 
epilepsy6 resulted in just over 50% increase in the incidence of new diagnosis 
of epilepsy compared to the 1993 definition.5 We found that seizures, epilepsy 
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Figure titles and legends  
 
Figure 1. Study overview.  
Multiple overlapping retrospective and prospective case ascertainment 
methods were applied to the defined area from 1st January 2017 to 31st March 
2018 to identify all potential cases of first seizure and new diagnosis of 
epilepsy that occurred during the calendar year 2017. Included cases 
(n=1264) were categorised as definite, probable or possible first single 
seizure (provoked or unprovoked) or new diagnosis of epilepsy based on 
ILAE epidemiologic guidelines.4 Cases in whom an alternate diagnosis was 
reached were classified as seizure mimics. *Eight cases had both a first 
provoked and first unprovoked seizure during the study period. ** One case of 
a first provoked seizure was deemed to also be at significantly increase risk of 
recurrent seizures and was therefore also classified as epilepsy. EEG= 
electroencephalogram, yr= years. 
 
Figure 2. Unadjusted annual incidence rates.  
Unadjusted age group specific annual incidence for definite and probable first 
unprovoked seizures, first provoked seizures, new diagnosis of epilepsy and 
seizure mimics per 100,000 population during the calendar year 2017.  
 
Figure 3. The annual incidence of epilepsy according to the 19935 and 20146 
ILAE definitions.  
The unadjusted annual incidence of definite and probable new diagnosis of 
epilepsy according to the 1993 and 2014 ILAE definitions of epilepsy in the 











Figure 4. The annual incidence of all first seizures compared to all seizure 
mimics. Unadjusted age group specific annual incidence of all definite and 

























Table 1. The sex-specific, age-group specific and total unadjusted and age- 
standardised incidence of all definite and probable first seizures, definite and 
probable first unprovoked seizures, definite and probable first provoked 
seizures, definite and probable new diagnosis of epilepsy and seizure mimics 
in the defined geographical area for the calendar year 2017. M:F Ratio= male 
to female incidence ratio.  
 
 
The sex-specific, age-group specific and total unad justed and age- standardised incidence of all defin ite and probable first seizures, definite and proba ble first 
unprovoked seizures, definite and probable first pr ovoked seizures, definite and probable new diagnosi s of epilepsy and seizure mimics in the defined geo graphical 
area for the calendar year 2017. 
Annual incidence of all first sezirues   
Age groups Males Cases Incidence Females Cases Incidence Total population Cases Incidence  
<1 3677 7 190 3466 5 144 7143 12 168 
1-4 15491 23 148 15008 8 53 30499 31 102 
5-9 20625 18 87 19820 10 50 40445 28 69 
10-14 18191 19 104 17253 8 46 35444 27 76 
15-24 33952 28 82 33394 15 45 67346 43 64 
25-34 35248 41 116 37596 16 43 72844 57 78 
35-44 41970 26 62 42861 17 40 84831 43 51 
45-54 36309 28 77 36000 17 47 72309 45 62 
55-64 29092 41 141 29072 29 100 58164 70 120 
65-74 21084 40 190 21732 32 147 42816 72 168 
75-84 10440 52 498 12822 40 312 23262 92 395 
>85 2596 9 347 5169 24 464 7765 33 425 
Total 268675 332 124 274193 221 81 542868 553 102  
95%CI   (111-138)   (71-92)   94-11 
 Male:female incidence ratio  1.53 Age standardised incidence  123 
 
Annual incidence of first unprovoked seizures   
Age groups Males Cases Incidence Females Cases Incidence Total population Cases Incidence  
<1 3677 6 163 3466 4 115 7143 10 140 
1-4 15491 20 129 15008 7 47 30499 27 89 
5-9 20625 16 78 19820 9 45 40445 25 62 
10-14 18191 19 104 17253 8 46 35444 27 76 
15-24 33952 19 56 33394 11 33 67346 30 45 
25-34 35248 19 54 37596 9 24 72844 28 38 
35-44 41970 14 33 42861 12 28 84831 26 31 
45-54 36309 17 47 36000 13 36 72309 30 41 
55-64 29092 21 72 29072 14 48 58164 35 60 
65-74 21084 27 128 21732 23 106 42816 50 117 
75-84 10440 29 278 12822 33 257 23262 62 267 
>85 2596 7 270 5169 15 290 7765 22 283 
Total 268675 214 80 274193 158 58 542868 372 69 
95%CI   70-91   49-67   62-76 
 Male:female incidence ratio  1.38 Age standardised incidence  83 
 










Age groups Males Cases Incidence Females Cases Incidence Total population Cases Incidence  
<1 3677 1 27 3466 1 29 7143 2 28 
1-4 15491 3 19 15008 1 7 30499 4 13 
5-9 20625 3 15 19820 1 5 40445 4 10 
10-14 18191 0 0 17253 0 0 35444 0 0 
15-24 33952 9 27 33394 4 12 67346 13 19 
25-34 35248 23 65 37596 7 19 72844 30 41 
35-44 41970 15 36 42861 5 12 84831 20 24 
45-54 36309 11 30 36000 4 11 72309 15 21 
55-64 29092 21 72 29072 15 52 58164 36 62 
65-74 21084 13 62 21732 11 51 42816 24 56 
75-84 10440 23 220 12822 7 55 23262 30 129 
>85 2596 2 77 5169 9 174 7765 11 142 
Total 268675 124 46 274193 65 24 542868 189 35  
95%CI  39-55    19-30   30-40 
 Male:female incidence ratio  1.95 Age standardised incidence  42 
 
Annual incidence of new diagnosis of epilepsy accor ding to the 2014 ILAE definition  
Age groups Males Cases Incidence Females Cases Incidence Total population Cases Incidence  
<1 3677 5 136 3466 2 58 7143 7 98 
1-4 15491 16 103 15008 6 40 30499 22 72 
5-9 20625 16 78 19820 9 45 40445 25 62 
10-14 18191 16 88 17253 8 46 35444 24 68 
15-24 33952 16 47 33394 12 36 67346 28 42 
25-34 35248 16 45 37596 9 24 72844 25 34 
35-44 41970 13 31 42861 7 16 84831 20 24 
45-54 36309 16 44 36000 12 33 72309 28 39 
55-64 29092 20 69 29072 13 45 58164 33 57 
65-74 21084 25 119 21732 22 101 42816 47 110 
75-84 10440 26 249 12822 31 242 23262 57 245 
>85 2596 6 231 5169 14 271 7765 20 258 
Total 268675 191 71 274193 145 53 542868 336 62  
95%CI   62-82   45-62   56-69 
 Male:female incidence ratio  1.34 Age standardised incidence  74 
Annual incidence of seizure mimics   
Age groups Males Cases Incidence Females Cases Incidence Total population Cases Incidence  
<1 3677 10 272 3466 8 231 7143 18 252 
1-4 15491 19 123 15008 11 73 30499 30 98 
5-9 20625 16 78 19820 11 55 40445 27 67 
10-14 18191 17 93 17253 13 75 35444 30 85 
15-24 33952 24 71 33394 49 147 67346 73 108 
25-34 35248 18 51 37596 24 64 72844 42 58 
35-44 41970 20 48 42861 37 86 84831 57 67 
45-54 36309 28 77 36000 22 61 72309 50 69 
55-64 29092 27 93 29072 34 117 58164 61 105 
65-74 21084 25 119 21732 27 124 42816 52 121 
75-84 10440 21 201 12822 28 218 23262 49 211 
>85 2596 12 462 5169 9 174 7765 21 270 
Total 268675 237 88 274193 273 100 542868 510 94  




















Table 2. The sex-specific, age-group specific and total crude and age- 
standardised incidence of definite and probable new diagnosis made 
according to the 1993 ILAE definition of epilepsy.5 M:F Ratio= male to female 
incidence ratio.  
 
The sex-specific, age-group specific and total crud e and age- standardised incidence of definite and p robable new 
diagnosis made according to the 1993 ILAE definitio n of epilepsy. 
Age groups Males Cases Incidence Females Cases Incidence Total population Cases Incidence  
<1 3677 4 109 3466 2 58 7143 6 84 
1-4 15491 10 65 15008 5 33 30499 15 49 
5-9 20625 15 73 19820 8 40 40445 23 57 
10-14 18191 10 55 17253 7 41 35444 17 48 
15-24 33952 14 41 33394 11 33 67346 25 37 
25-34 35248 10 28 37596 7 19 72844 17 23 
35-44 41970 10 24 42861 4 9 84831 14 17 
45-54 36309 7 19 36000 6 17 72309 13 18 
55-64 29092 9 31 29072 6 21 58164 15 26 
65-74 21084 16 76 21732 16 74 42816 32 75 
75-84 10440 14 134 12822 20 156 23262 34 146 
>85 2596 4 154 5169 6 116 7765 10 129 
Total 268675 123 46 274193 98 36 542868 221 41  
95%CI   38-55   29-44   36-46 
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Table 3. Comparison of case ascertainment methods, crude and age-adjusted incidence values from previous studies investigating 
the incidence of epilepsy and/or first seizures in all ages within a defined population. Studies included were whole population 
studies including both adults and children over 28 days old. AED =Anti-epileptic drug. EEG= electroencephalogram. RASC= Rapid 
Access Seizure Clinic. GP= General practitioner.  
Comparison of case ascertainment methods, crude and age-adjusted incidence values from previous studies investigating the incidence of epilepsy and/or first seizures in all ages within a defined population. Studies included were whole population studies including both adults and 
























































































































Case ascertainment                     
Radiology database X      X              
EEG database X      X         X  X  X 
Emergency Department X    X  X              
Neurologists/Paediatricians X    X  X           X   
Other hospital specialists X      X              
RASC X        X            
Clinical Nurse Specialist X                    
GP survey X      X  X       X  X   
Residential care survey X    X  X              
Patient Advocacy Group X                    
Hospital medical record 
data 
 X X  X X   X X   X X    X X X 
Door to door survey    X    X   X X   X  X    
School teachers and social 
workers 
                 X   
Crude incidence of epilepsy 
(per 100,000) 1993 ILAE 
definition 
41 63  53.41 81  68.8  33.3 92.7   35.5  49.3  64   113  73.3  42.8   33.1 48.7  32.8  
Age-adjusted incidence of 


















 46 adjusted 
to U.K. 















Incidence of epilepsy (per 
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